Disc Medicine’s Myelofibrosis Drug Shows Breakthrough Results in Phase 1b Trial with 100% Response Rate StockTitan Nawigacja wpisu Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting – GlobeNewswire China unveils TCM training scheme for belt and road countries – South China Morning Post
